FDA Approves New Treatment for Thyroid Eye Disease

• by Kathryn Wighton

• June 29, 2026

Depression, anxiety symptoms may be common in T1D

National survey data show a greater mental health symptom burden among adults with type 1 diabetes vs. those with type 2 diabetes or no diabetes.

• by Andrea Surnit

• October 19, 2026

• 4 min

FDA, CMS target gene therapy barriers

FDA and CMS initiatives aim to simplify gene therapy approvals and expand access to treatments for rare diseases.

• by Mouj Hijazi

• October 29, 2026

• 4 min

The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.

“Doctors rely on this evidence, patients rely on this evidence, and if that evidence is not there, it’s going to lead to a lot of uncertainty."

• by David Hilzenrath

• September 22, 2026

• 14 min